PEPD and metabolic dysfunction-associated steatohepatitis: In subjects with chronic liver disease (chronic hepatitis B and C) and nonalcoholic steatohepatitis, serum prolidase activity has been shown to increase, especially in the early stage of fibrosis [20–23].